Vaccsys raises $9 million for vaccine research
Vaccsys, a company that does vaccine research, has raised $9 million of a planned $18 million round from Alta Partners, Versant Venture Capital and The Column Group.
Vaccsys’s web site is here, although it’s still under construction.
Update: As part of the new funding, Vaccsys is relaunching under a new name, Immune Design, according to VentureWire.
Next Story: PartnerUp’s Weekly Opportunities
Previous Story: Presidential candidate debates arrive on Twitter
About the Author, Eric Eldon
Eric currently covers digital media technology and business news, especially what's happening on social networks and their platforms. He also writes and edits stories about venture capital, and lots of other stuff, too. He started at VentureBeat in the spring of 2007, half a year or so after Matt Marshall left his reporting job at the San Jose Mercury News to found the site. Eric previously cofounded a startup called Writewith, that was building editorial software for newspapers and other groups of writers. The startup didn't work out, but he learned a lot.